Gui Zhi

Presentation Slides

Chinese Medicine Research Hub

Network Pharmacology

The Gui Zhi-Shao Yao herb pair in traditional Chinese medicine potentially treats chronic pain, anxiety, and depression through interactions with nine key targets.

2022 Annals of Medicine A network pharmacology approach to predict potential targets and mechanisms of “Ramulus Cinnamomi (cassiae) – Paeonia lactiflora” herb pair in the treatment of chronic pain with comorbid anxiety and depression
Pan HT, Xi ZQ, Wei XQ, Wang K

Chinese Medicine Research Hub

Study Protocol

Gynoclear™, a formulation of six herbs, could potentially reduce the severity and duration of pain and other symptoms associated with endometriosis.

2021 BMC Complementary Medicine and Therapies The effectiveness of a modified Gui Zhi Fu Ling Wan formulation (Gynoclear™) for the treatment of endometriosis: a study protocol for a placebo-controlled, double-blind, randomised controlled trial
Armour M, Al-Dabbas MA, Ee C, Smith CA, Ussher J, Arentz S, Lawson K, Abbott J

Chinese Medicine Research Hub

Systematic Review

Gui Zhi Decoction and associated formulas significantly improve the effectiveness of allergic rhinitis treatments when used alone or combined with Western medicine.

2021 Evidence-Based Complementary and Alternative Medicine Efficacy and Safety of Guizhi Decoction AssociatedFormulas for Allergic Rhinitis: A Systematic Review
Yang S, Fu Q, Deng H, Wu J, Zhang Q, Wang L, Yao X

Chinese Medicine Research Hub

Experimental Study

Gui Zhi Fu Ling Wan can potentially reduce and induce apoptosis in uterine leiomyomas cells.

2019 Frontiers in Pharmacology Gyejibongnyeong-Hwan (Gui Zhi Fu Ling Wan) Ameliorates Human Uterine Myomas via Apoptosis
Lee SM, Choi ES, Ha E, Ji KY, Shin SJ, Jung J

Chinese Medicine Research Hub

Network Pharmacology

Guizhi Fuling Wan, a traditional herbal formula, can improve peripheral blood flow in menopausal hot flush sufferers, despite not changing the frequency or severity of the flushes.

2019 Biomedicines A Classic Herbal Formula Guizhi Fuling Wan for Menopausal Hot Flushes: From Experimental Findings to Clinical Applications
Li , Hung , Li , Yang

Executive Summary

Write an executive summary in the form of a blog article on the topic of "Research into Chinese medicine treatment for Gui Zhi" summarising the research below and using language that can be easily understood by patients and avoiding medical jargon using a professional and caring tone of voice.

Write an executive summary in the form of a blog article on the topic of "Researched Chinese medicine treatments for Gui Zhi" summarising the research below in an objective and easy to understand way, and using language that can be easily understood by patients. Group the article into Chinese medicine treatments first, followed by nutrition and other treatments. Avoid using medical jargon and use a professional and caring tone of voice.

Write me a concise but easy to understand executive summary on the topic of "Chinese medicine treatments for Gui Zhi" based on the following research that I will give you. Your summary should be 2 paragraphs long in Australian English spelling and include references to the studies.

A Network Pharmacology published in 2022 in the journal Annals of Medicine found that The Gui Zhi-Shao Yao herb pair in traditional Chinese medicine potentially treats chronic pain, anxiety, and depression through interactions with nine key targets. The methodology in this research utilised network pharmacology to explore the active components of the "Gui Zhi-Shao Yao" herb pair and their possible targets. Initially, 15 active compounds were identified through a series of analysis which revealed about 130 potential targets. By considering the intersections between the targets of the "Gui Zhi-Shao Yao" herb pair and chronic pain, anxiety disorder, and mental depression, nine vital targets were identified and listed in order of importance. The results discussion revealed that the "Gui Zhi-Shao Yao" herb pairing acted on the nine identified key targets to alleviate chronic pain, anxiety, and depression. Gene ontology and pathway analysis demonstrated that there were 11 primary pathways, including AGE-RAGE signalling pathway, IL-17 signalling pathway, and TNF signalling pathway. These pathways appear to be actively involved in the pathological processes, providing a holistic understanding of how the "Gui Zhi-Shao Yao" herb pair functions therapeutically.

A Study Protocol published in 2021 in the journal BMC Complementary Medicine and Therapies found that Gynoclear™, a formulation of six herbs, could potentially reduce the severity and duration of pain and other symptoms associated with endometriosis. The methodology consisted of a randomized, double-blind, placebo-controlled trial with a minimum of 90 participants across Australia who have confirmed endometriosis and moderate or greater pelvic pain. These participants were equally divided to receive either Gynoclear™ or a placebo. Gynoclear's active ingredients consist of six herbs, namely Safflower, Chinese cinnamon, Hoelen, Tree peony, Peony, and Red sage. The participants were required to document their pain experiences for a total of five months, which included a month of screening, two months of treatment, and a month post-treatment. The main variable being studied was the change in endometriosis-related pain. The results of the study aimed to establish the efficacy of Gynoclear™ in reducing endometriosis-related pain and other symptoms. Secondary outcomes encompassed change in health-related quality of life, alterations in the use of rescue analgesics, and changes in sexual discomfort and fatigue. The practicality and usefulness of Gynoclear™ intended to serve both healthcare professionals and individuals suffering from endometriosis.

A Systematic Review published in 2021 in the journal Evidence-Based Complementary and Alternative Medicine found that Gui Zhi Decoction and associated formulas significantly improve the effectiveness of allergic rhinitis treatments when used alone or combined with Western medicine. The study aimed to evaluate the efficacy of Guizhi Decoction and associated formulas for treating allergic rhinitis. It included a comprehensive search of seven online databases for studies published until February 23, 2020. Each selected study's quality was assessed using the Cochrane Collaboration risk of bias tool. The research used systematic reviews based on the Cochrane systematic review method, facilitated by RevMan 5.3 Software. Interventions in the study varied from using Guizhi Decoction and associated formulas alone to combining them with Western medicine, acupoint-based therapy, Chinese patent medicine, and placebo control. Data from 23 trials involving 2281 participants were collected and systematically analysed. The results showed that Guizhi Decoction and associated formulas, either alone or in conjunction with Western medicine or acupoint-based therapies, exhibited higher efficacy compared to Western medicine alone. The study also reported that adding nasal traditional Chinese medicine fumigation therapy to the Guizhi Decoction formulations could further improve treatment effectiveness. Adverse events were primarily mild and primarily associated with the control groups that used Western medicine alone, requiring no specific medical intervention.

A Experimental Study published in 2019 in the journal Frontiers in Pharmacology found that Gui Zhi Fu Ling Wan can potentially reduce and induce apoptosis in uterine leiomyomas cells. In the study, human uterine myoma cells (hUtMCs) were collected from patients who had undergone surgery for this condition. The viability of these cells was tested when exposed to various doses of Gyejibongnyeong-hwan (GBH). Determination of adequate concentration for the treatment was also performed, ensuring that it did not affect normal cells adversely. Western blotting was employed to identify the expression levels of certain proteins that indicate cellular apoptosis, while the levels of reactive oxygen species were evaluated through fluorescence microscopy. Finally, the researchers looked into the time-dependent anti-neoplastic effect of GBH in order to establish an appropriate treatment duration under a non-harmful concentration of the medication. The results showed that Gyejibongnyeong-hwan (GBH) drastically reduced the viability and number of hUtMCs within 48 hours in a dose-dependent manner. It was identified that the ratio of certain proteins and the expression of other apoptosis-related ones increased, suggesting that GBH induced cellular self-destruction in uterine leiomyomas. Moreover, it was shown that GBH noticeably increased the mitochondrial concentration of reactive oxygen species. Conversely, by using certain inhibitors along with GBH, the apoptotic effect mediated by GBH was mitigated. This evidence suggests that GBH could potentially trigger apoptosis of leiomyomas and hence, presents a promising therapeutic agent in managing uterine leiomyomas.

A Network Pharmacology published in 2019 in the journal Biomedicines found that Guizhi Fuling Wan, a traditional herbal formula, can improve peripheral blood flow in menopausal hot flush sufferers, despite not changing the frequency or severity of the flushes. The methodology used in this study involved a comprehensive literature search across 20 English and Chinese databases for relative clinical and experimental studies. From the nearly 13,000 studies identified, only 46 were evaluated as relevant and thus included in the review. These articles were comprised of seven clinical studies detailing Guizhi Fuling Wan's effects on menopausal hot flushes and 35 phytochemical analysis studies that identified the 169 chemical compounds in the herbal formula. Four experimental studies were also utilized to discover the potential therapeutic effects and target proteins/cytokines related to these hot flushes. The findings indicate that Guizhi Fuling Wan, despite exhibiting no significant impact on the frequency or severity of menopausal hot flushes, may have positive effects on peripheral blood flow. The blood flow improvements were specifically noted in the fingertips, jaw, and toes. Additionally, the analysis of the herbal formula revealed 169 distinct chemical compounds. Through experimental studies, potential therapeutic effects on target proteins/cytokines - including estrogen receptor beta with genetic variation, the calcitonin gene-related peptide receptor, and interleukin-8, were further highlighted. However, these therapeutic effects were inconsistent across different studies, which may be due to dosage differences and genotype variation.

Moderation Tools

Topic